Narrative review of endocrine and molecular mechanisms of oocyte aging
This narrative review links age-related endocrine changes and molecular dysfunction to declining oocyte quality; proposed interventions have shown potential mainly in animal and preclinical models, not proven benefit in women. [1]
Automatic summary · not editorially reviewed
The key findings
The review distinguishes ovarian aging, covering follicular depletion and endocrine and somatic-cell changes, from oocyte aging, the age-associated decline in the oocyte's molecular, cellular and developmental competence. [1]
The review suggests that endocrine dysregulation may converge with mitochondrial, metabolic, telomere and epigenetic changes to compromise oocyte meiotic competence and developmental potential. [1]
Antioxidants, NAD restoration, mitochondrial transfer and exosome-based interventions showed potential mainly in animal and preclinical models; none has been shown to delay physiological oocyte aging in women. [1]
The source at a glance
- Study type / format
- Narrative review (abstract only)
- Population / context
- Oocytes and ovarian tissue in the context of reproductive aging, as discussed in the review
- Summary based on
- Study abstract
- Original publication
- September 19, 2026
Ovarian versus oocyte aging in the review
The review treats ovarian aging and oocyte aging as closely connected but distinct. Ovarian aging covers progressive follicular depletion and changes in ovarian endocrine and somatic-cell function. Oocyte aging refers more specifically to age-associated deterioration in the molecular, cellular and developmental competence of the oocyte. This deterioration is described as contributing to increased aneuploidy, impaired embryonic development, implantation failure and early pregnancy loss.
Supporting source [1]
Endocrine and molecular mechanisms proposed
The review suggests that age-related dysregulation of the hypothalamic-pituitary-ovarian axis, altered gonadotropin signaling and changes in intraovarian endocrine and paracrine communication may disrupt follicular development and the follicular microenvironment. These changes may compromise interactions between the oocyte and surrounding somatic cells. They may converge with mitochondrial dysfunction, oxidative stress, mtDNA abnormalities, impaired energy metabolism, altered telomere biology and epigenetic dysregulation, ultimately compromising meiotic competence and developmental potential. The wording is tentative throughout.
Supporting source [1]
Experimental strategies and their evidence limits
Experimental strategies named in the review include antioxidant supplementation, restoration of NAD metabolism, mitochondrial transfer and exosome-based interventions. They have shown potential to ameliorate features of oocyte aging, primarily in animal and preclinical models. However, none has been shown to delay physiological oocyte aging in women, and evidence on clinical effectiveness and long-term safety remains insufficient. The review proposes that understanding these interactions may help identify biomarkers and targeted approaches.
Supporting source [1]
How to interpret this
This is an abstract of a narrative review; the full text was not reviewed. The abstract reports no study design details, sample sizes, follow-up or outcome data, and the intervention evidence is described as mainly animal and preclinical, with insufficient clinical effectiveness and long-term safety data.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Fotara M, Moustakli E, Daskalaki MA, Mavrogianni D, Arkoulis I, Topis S, Potiris A, Louis K, Kathopoulis N, Domali E, Daskalakis G, Stavros S. · europepmc.org · September 19, 2026